Works matching IS 02770008 AND DT 2016 AND VI 36 AND IP 10

Results: 11

Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. e160, doi. 10.1002/phar.1830

By:

Marino, Kaylee K.;
Santiago, Raul A.;
Dew, Richard B.;
Berliner, Nancy;
Connors, Jean M.;
Connell, Nathan T.;
Tucker, John Kevin

Publication type:

Article

Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1055, doi. 10.1002/phar.1831

By:

Blackburn, David F.;
Evans, Charity D.;
Eurich, Dean T.;
Mansell, Kerry D.;
Jorgenson, Derek J.;
Taylor, Jeff G.;
Semchuk, William M.;
Shevchuk, Yvonne M.;
Remillard, Alfred J.;
Tran, David A.;
Champagne, Anne P.

Publication type:

Article

Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1065, doi. 10.1002/phar.1826

By:

Afanasjeva, Janna;
Hui, Rita L.;
Spence, Michele M.;
Chang, Jennifer;
Schottinger, Joanne E.;
Millares, Mirta;
Rashid, Nazia

Publication type:

Article

Value of a Community-Based Medication Management Review Service in Jordan: A Prospective Randomized Controlled Study.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1075, doi. 10.1002/phar.1833

By:

Basheti, Iman A.;
Tadros, Odate K. I.;
Aburuz, Salah

Publication type:

Article

Issue Information.

Published in:: Pharmacotherapy, 2016, v. 36, n. 10, p. 1043, doi. 10.1002/phar.1838
Publication type:: Article

Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1087, doi. 10.1002/phar.1824

By:

Nedved, Adrienne N.;
DeFrates, Sean R.;
Hladnik, Lindsay M.;
Stockerl‐Goldstein, Keith E.

Publication type:

Article

A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1095, doi. 10.1002/phar.1832

By:

McConeghy, Kevin W.;
Soriano, Melinda M.;
Danziger, Larry H.

Publication type:

Article

Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1047, doi. 10.1002/phar.1827

By:

Kwon, Jennifer O.;
MacLaren, Robert

Publication type:

Article

Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1109, doi. 10.1002/phar.1828

By:

Weeda, Erin R.;
Kohn, Christine G.;
Peacock, W. Frank;
Fermann, Gregory J.;
Crivera, Concetta;
Schein, Jeff R.;
Coleman, Craig I.

Publication type:

Article

An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger than 2 Years Old.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1102, doi. 10.1002/phar.1829

By:

Zembles, Tracy N.;
Thompson, Nathan E.;
Havens, Peter L.;
Kaufman, Bruce A.;
Huppler, Anna R.

Publication type:

Article

Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. e154, doi. 10.1002/phar.1825

By:

Vickery, Stephen B.;
McClain, David;
Wargo, Kurt A.

Publication type:

Article